Srsf1 and Elavl1 act antagonistically on neuronal fate choice in the developing neocortex by controlling TrkC receptor isoform expression
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von A Ioana Weber und 12 weiteren Autor:innen. Beteiligte Einrichtung: Charité Universitätsmedizin Berlin, Institute of Cell Biology and Neurobiology, Charitéplatz 1, 10117 Berlin, Germany. Hauptthemen laut MEDLINE: Neocortex, Receptor, trkC. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DFG, Russian Science Foundation, Boehringer Ingelheim Fonds.
Abstract (Originalsprache)
The seat of higher-order cognitive abilities in mammals, the neocortex, is a complex structure, organized in several layers. The different subtypes of principal neurons are distributed in precise ratios and at specific positions in these layers and are generated by the same neural progenitor cells (NPCs), steered by a spatially and temporally specified combination of molecular cues that are incompletely understood. Recently, we discovered that an alternatively spliced isoform of the TrkC receptor lacking the kinase domain, TrkC-T1, is a determinant of the corticofugal projection neuron (CFuPN) fate. Here, we show that the finely tuned balance between TrkC-T1 and the better known, kinase domain-containing isoform, TrkC-TK+, is cell type-specific in the developing cortex and established through the antagonistic actions of two RNA-binding proteins, Srsf1 and Elavl1. Moreover, our data show that Srsf1 promotes the CFuPN fate and Elavl1 promotes the callosal projection neuron (CPN) fate in vivo via regulating the distinct ratios of TrkC-T1 to TrkC-TK+. Taken together, we connect spatio-temporal expression of Srsf1 and Elavl1 in the developing neocortex with the regulation of TrkC alternative splicing and transcript stability and neuronal fate choice, thus adding to the mechanistic and functional understanding of alternative splicing in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Charité Universitätsmedizin Berlin, Institute of Cell Biology and Neurobiology, Charitéplatz 1, 10117 Berlin, Germany.
- Freie Universität Berlin, Institute of Chemistry and Biochemistry, Takustr. 6, 14195, Berlin, Germany.
- Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634009, Tomsk, Russia.
- Institute of Neuroscience, Lobachevsky State University of Nizhny Novgorod, 603950, Nizhny Novgorod Oblast, Russia.
- Heinrich Heine Universität Düsseldorf, Institute of Virology, Medical Faculty, Universitätsstr. 1, 40225 Düsseldorf, Germany.
ORCID-Profile: A Ioana Weber, Paraskevi Bessa, Andrew G Newman, Florian Heyd
Förderung
- DFG
- Russian Science Foundation
- Boehringer Ingelheim Fonds
- Charité Universitätsmedizin Berlin
Zitieren
APA
Weber, A. I., Parthasarathy, S., Borisova, E., Epifanova, E., Preußner, M., Rusanova, A., Ambrozkiewicz, M. C., Bessa, P., Newman, A. G., Müller, L., Schaal, H., Heyd, F., & Tarabykin, V. (2023). Srsf1 and Elavl1 act antagonistically on neuronal fate choice in the developing neocortex by controlling TrkC receptor isoform expression. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad703
Vancouver
Weber AI, Parthasarathy S, Borisova E, Epifanova E, Preußner M, Rusanova A, et al. Srsf1 and Elavl1 act antagonistically on neuronal fate choice in the developing neocortex by controlling TrkC receptor isoform expression. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad703
BibTeX
@article{Weber2023,
author = {Weber, A Ioana and Parthasarathy, Srinivas and Borisova, Ekaterina and Epifanova, Ekaterina and Preußner, Marco and Rusanova, Alexandra and Ambrozkiewicz, Mateusz C and Bessa, Paraskevi and Newman, Andrew G and Müller, Lisa and Schaal, Heiner and Heyd, Florian and Tarabykin, Victor},
title = {Srsf1 and Elavl1 act antagonistically on neuronal fate choice in the developing neocortex by controlling TrkC receptor isoform expression},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad703}
}
EUVIMED